Filed under: Drug, All Cancers
It's interesting when a drug is re-purposed into something aimed at fighting cancer, but that is what has happened to Evista, a prescription drug made by Eli Lilly which was originally for osteoporosis patients.
The FDA has officially approved Evista for use in
breast cancer patients as of late this week, although the drug will now come with a box warning advising patients of a heightened risk for stroke by taking the drug.
I'm not sure -- are some drugs worth the possible benefits when certain side effects can be just as bad as what is trying to be treated?
